Heavy ligands such as polyoxometalates are opening a new frontier in actinide chemistry. Studying materials that are both ...

Proteins in the sheath of cellular protrusions control how effectively cells can adhere to surfaces. Biological cells often ...

Mandimycin is structurally similar to the last-line-of-defense antifungal amphotericin B, another glycosylated polyene macrolide. But instead of binding to ergosterol in the fungal cell membrane as ...

Elevidys, Sarepta’s gene therapy for DMD, has demonstrated significant commercial success since receiving expanded label approval for patients aged 6 and older. The therapy has exceeded revenue ...

A patient died from liver injury while taking the gene therapy Elevidys Sarepta says more than 800 patients have received the treatment The company plans to update prescribing information after ...

Elevidys, Sarepta’s gene therapy for DMD, has demonstrated significant commercial success since receiving expanded label approval for patients aged 6 and older. The therapy has exceeded revenue ...

Sarepta fell heavily by 27.44 percent on Tuesday to finish at $73.54 apiece as investors disposed of shares in the company following twin news of death associated with its treatment Elevidys.

The patient in this case had suffered acute liver failure following the Elevidys infusion. Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy (DMD) who received ...

A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment. The company behind the drug, Sarepta ...

However, the "severity" of this case had not been seen before, the company noted. Elevidys has been used in more than 800 patients, the company stated. Sarepta did not release details about the ...